In addition, the over-expression of CMC4 (also known as MTCP1), as a favorable prognosis gene in our model, was discordantly reported to produce clonal CD5+/CD19+ leukemia in mice (45), which was thought to be a chronic lymphocytic leukemia driving gene. The gene discussed is CD19; the disease is B-cell chronic lymphocytic leukemia.